CRDF
#4032
Cardiff Oncology, Inc. - Common Stock
1.3 1 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.96%
Monthly Change
-9.66%
6 month change
-53.21%
Year Change
-68.28%
Previous Close
1.3 5
Open
1.3 1
Low
1.3 1
High
1.3 1
Volume
94
Financials
- Market Capitalization 89.56 M
- Employee 31
- Founded 1999
- CEO Mark Erlander
- Website www.cardiffoncology.com
- Headquarter Delaware, United States
- FIGI BBG000PXLKM7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.07
Price to sales ratio
316.73
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4019 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.13 USD | +7.58% | +14.52% | +40.13% | +65.12% | 91.17 M USD | ||
| 4023 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.01 USD | -0.98% | -6.48% | -17.21% | +57.81% | 90.39 M USD | ||
| 4034 |  LONA LeonaBio, Inc. - Common Stock | 9.52 USD | -2.46% | +12.13% | +12.40% | +41.25% | 89.43 M USD | ||
| 4042 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.45 USD | +2.11% | -3.97% | +7.41% | -30.29% | 88.16 M USD |
Frequently asked questions about Cardiff Oncology, Inc. - Common Stock
What is the Cardiff Oncology, Inc. - Common Stock stock price today?
The current price of Cardiff Oncology, Inc. - Common Stock (CRDF) is 1.31. Over the past 24 hours, the stock has changed by -2.96%. Follow the CRDF chart for real-time price dynamics.
What is the stock ticker of Cardiff Oncology, Inc. - Common Stock?
Cardiff Oncology, Inc. - Common Stock trades under the ticker CRDF. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cardiff Oncology, Inc. - Common Stock stock going up?
CRDF has changed by 0.00% over the last week, -9.66% over the last month, and -68.28% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cardiff Oncology, Inc. - Common Stock net income for the last quarter?
Cardiff Oncology, Inc. - Common Stock reported net income of -12.35 M for the last quarter. The previous quarter showed -7.22 M, which means net income changed by -71.08%.
How many employees does Cardiff Oncology, Inc. - Common Stock have?
As of the latest available data, Cardiff Oncology, Inc. - Common Stock has 31 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cardiff Oncology, Inc. - Common Stock EBITDA?
Cardiff Oncology, Inc. - Common Stock EBITDA is -12.76 M, and its EBITDA margin is -31.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cardiff Oncology, Inc. - Common Stock stock?
You can buy Cardiff Oncology, Inc. - Common Stock (CRDF) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cardiff Oncology, Inc. - Common Stock stock?
Investing in Cardiff Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRDF chart and related analysis on metatrader.com as part of your research.